Racially diverse clinical trials: A new patient-led legacy takes root

Attempts to make trials more diverse aren’t working. To overcome far-reaching inequality and deep distrust, pharma must be educated by, as well as educate, under-served communities

Patients and Medical

Patient engagement: Breaking through in digital

Face-to-face engagement restrictions during the pandemic made remote engagement the only game in town for pharma and...

Commercial

Australia’s field force: evolving on fast forward

The pandemic has, it will surprise no one, upended traditional ways of working for pharma’s Australian field force. “I...

Latest

Patients and Medical
Racially diverse clinical trials: A new patient-led legacy takes root

Andrew Stone, (Oct 15, 2020)

Attempts to make trials more diverse aren’t working. To overcome far-reaching inequality and deep distrust, pharma must be educated by, as well as educate, under-served communities
Patients and Medical
Patient engagement: Breaking through in digital

Andrew Stone, (Oct 14, 2020)

The pandemic is serving as an accelerated lesson in the possibilities of digital engagement. Now pharma must work out how to harness its full potential
Commercial
Adapting to the multichannel imperative: A special report

Andrew Stone, (Oct 8, 2020)

Pharma’s gradual evolution into digital-first commercial has become urgent in the COVID-19 world. A comprehensive multi-channel approach including the use of digital tools to enhance customer engagement will transform pharma sales.
Multichannel
COVID-19: The tipping point for rapid tech adoption

Andrew Stone, (Oct 2, 2020)

A new pandemic-driven technological revolution is reshaping the entire healthcare system in 2020 and everyone’s sense of what is possible beyond it
Patients and Medical
Amplifying the patient voice in rare disease access

Elly Aylwin-Foster, (Oct 2, 2020)

Rare disease patients are organising like never before, turning up the publicity volume and becoming ever more active in driving cures in the lab and even the boardroom

Opinion

Up Close and Personal: A Life of Service - The Dr. Dirk Vander Mijnsbrugge Story

Jill Donahue, (Oct 2, 2020)

Pfizer's Medical Affairs Lead, Rare Diseases, talks about purpose, patients and pharma's power to do good

Up close and personal: The Thomas D’Hooghe story

Jill Donahue, (Apr 14, 2020)

Merck's Thomas D’Hooghe shares his thoughts on passion, purpose, leading people and making a difference

More Columns

Commercial

Adapting to the multichannel imperative: A special report

Andrew Stone, (Oct 8, 2020)

Pharma’s gradual evolution into digital-first commercial has become urgent in the COVID-19 world. A comprehensive multi-channel approach including the use of digital tools to enhance customer engagement will transform pharma sales.
Australia’s field force: evolving on fast forward

Lucy Fulford, (Sep 16, 2020)

Australian pharma’s field force roles are changing fast and the new digital-first environment is driving a need for new approaches and new skillsets
Customer centricity in a changed world

Andrew Stone, (Apr 20, 2020)

Pharma’s marketeers are having to rapidly change their approach to customers, field force roles and digital in the midst of the pandemic
The changing nature of pharma sales: A conversation on many levels

Ulrich Neumann, (Feb 20, 2020)

The new approach to sales marries state of the art analytics with a classical approach to engagement
Time to embrace social media

Katie Osborne, (Feb 4, 2020)

Patients are turning to social media as never before and pharma needs to catch up

More Commercial

Access and Evidence

A burning desire to make a difference for patients

Andrew Stone, (Apr 19, 2020)

Annexus Health, eyeforpharma’s 2020 Health Start-up winner is on a mission for patients
From reactive to predictive: Concerto’s new compositions

Andrew Stone, (Apr 10, 2020)

Artificial Intelligence has only just begun to unlock high value innovation. The latest predictive tools will break new ground, says Concerto HealthAI’s Jeff Elton
Evolving HTA frameworks to accelerate innovation

Andrew Stone, (Mar 14, 2020)

Iterative evidence generation and demonstrating value over time could help unlock delays in getting cures out, saving more lives, says Janssen’s Clare Hague
Can we afford to pay for future cures?

Ulrich Neumann, (Jan 24, 2020)

Medical innovation is racing ahead of healthcare’s ability to innovate on payments, but new ideas are emerging
Advancing RWE together with academia

Katie Osborne, (Jan 2, 2020)

Pharma can realise the potential of RWE faster by collaborating more effectively with academia but first it must build trust

More Market Access

Patients and Medical

Digital companions: helping improve patient treatment journeys

Katie Osborne, (Oct 23, 2020)

The virtual health explosion isn't going away. This just at the start of an era of digital enhancement
Racially diverse clinical trials: A new patient-led legacy takes root

Andrew Stone, (Oct 15, 2020)

Attempts to make trials more diverse aren’t working. To overcome far-reaching inequality and deep distrust, pharma must be educated by, as well as educate, under-served communities
Patient engagement: Breaking through in digital

Andrew Stone, (Oct 14, 2020)

The pandemic is serving as an accelerated lesson in the possibilities of digital engagement. Now pharma must work out how to harness its full potential
Amplifying the patient voice in rare disease access

Elly Aylwin-Foster, (Oct 2, 2020)

Rare disease patients are organising like never before, turning up the publicity volume and becoming ever more active in driving cures in the lab and even the boardroom
From complexity to clarity in cell and gene therapy

Andrew Stone, (Sep 16, 2020)

Breakthrough CGT therapies are coming thick and fast, now pharma must work on multiple fronts to educate non-specialist stakeholders about their exciting possibilities

More Patients and Medical

Reuters Events | Pharma
Thought leadership and innovation for the Pharmaceutical Industry

Racially diverse clinical trials: A new patient-led legacy takes root

Patient engagement: Breaking through in digital

Australia’s field force: evolving on fast forward

Latest

Racially diverse clinical trials: A new patient-led legacy takes root

Patient engagement: Breaking through in digital

Adapting to the multichannel imperative: A special report

COVID-19: The tipping point for rapid tech adoption

Amplifying the patient voice in rare disease access

Most Popular

Opinion

Commercial

Adapting to the multichannel imperative: A special report

Australia’s field force: evolving on fast forward

Customer centricity in a changed world

The changing nature of pharma sales: A conversation on many levels

Time to embrace social media

Access and Evidence

A burning desire to make a difference for patients

From reactive to predictive: Concerto’s new compositions

Evolving HTA frameworks to accelerate innovation

Can we afford to pay for future cures?

Advancing RWE together with academia

Patients and Medical

Digital companions: helping improve patient treatment journeys

Racially diverse clinical trials: A new patient-led legacy takes root

Patient engagement: Breaking through in digital

Amplifying the patient voice in rare disease access

From complexity to clarity in cell and gene therapy

Latest Videos

Upcoming events

October 2020

November 2020

December 2020

May 2021

October 2021

In-Depth Analysis

Recent Press Releases

Login

Latest

Most Popular

Opinion

Commercial

Access and Evidence

Patients and Medical

Latest Videos

Upcoming events

October 2020

November 2020

December 2020

May 2021

October 2021

In-Depth Analysis

Recent Press Releases